<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=35476375865279447&ev=PageView&noscript=1"/>

Aurobindo Pharma Limited

NSE: AUROPHARMA · Lot size: 550

Aurobindo Pharma Limited Open Interest & PCR Analysis

1,398.2Updated 21 Apr 2026, 01:26 pm IST
PCR
0.70
Bearish signal
Max Pain
1,310
Spot above by ₹88
Total CE OI
3.62M
Call writers
Total PE OI
2.54M
Put writers
OI Buildup Signal
Neutral
Price movement < 0.3% threshold
Put-Call Ratio Gauge
0 — Bearish1.0 — Neutral2.0+ — Bullish

Data as of 2026-04-21

Frequently Asked Questions

What is Aurobindo Pharma Limited PCR (Put-Call Ratio) today?
Aurobindo Pharma Limited's current PCR is 0.70. A PCR above 1.2 is considered bullish (more put writing = floor support); below 0.8 is bearish; 0.8–1.2 is neutral. Aurobindo Pharma Limited's PCR of 0.70 indicates bearish sentiment.
What is Aurobindo Pharma Limited OI buildup type today?
Aurobindo Pharma Limited is currently showing neutral positioning with no significant directional bias. This is determined by comparing today's price change direction with the direction of total OI change — using the standard F&O buildup classification framework.
What is total CE and PE open interest for Aurobindo Pharma Limited?
Aurobindo Pharma Limited has total CE (call) OI of 3620100 contracts and total PE (put) OI of 2541000 contracts for the nearest expiry. The PCR is 0.70.
How is open interest analysis useful for Aurobindo Pharma Limited trading?
OI analysis for Aurobindo Pharma Limited helps identify institutional positioning. High CE OI at a strike = call writers defending that level (resistance). High PE OI = put writers defending that level (support). The buildup type tells you whether smart money is building fresh positions (bullish/bearish) or exiting existing ones.
What is the max pain for Aurobindo Pharma Limited?
Aurobindo Pharma Limited's max pain is ₹1,310 — the strike price where option writers (sellers) collectively suffer the least financial loss at expiry. The current spot price vs max pain deviation guides near-term directional bias into expiry.